FDA approves Biocompatibles' OC OTW (over-the-wire) stent:
This article was originally published in Clinica
The US FDA has approved for sale Biocompatibles International's BiodivYsio OC over-the-wire (OTW) coronary stent. The device is available in a variety of lengths - ranging from 11mm to 28mm - on OTW delivery systems of 3mm, 3.5mm and 4mm in diameter. The product completes the company's current BiodivYsio coronary stent product line, which includes the US-approved Added Support and the Small Vessel OTW stents. Biocompatibles' stents are coated with the Farnham, Surrey firm's phosphorylcholine (PC) technology - a biocompatible coating that reduces the body's response to medical devices. Abbott Laboratories is the US distributor of Biocompatibles' cardiovascular line.